Page 3 - Swedish (OMX) Pharmaceuticals & Biotech Stocks - Top Gainers Today

UPDATED Nov 21, 2024

Explore the Swedish (OMX) Top Gainers Today. These Pharmaceuticals & Biotech Stocks have seen the largest rise in Market Cap from the previous trading day.

116 companies
CompanyLast Price1D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield

IVACC

Intervacc
SEK 2.540%-63.5%SEK 192.4mSEK 8.00PS20.9xE26.6%n/a

TOL

Toleranzia
SEK 0.570%30.9%SEK 111.9mn/aPS3.2xn/an/a

PMED

PEPTONIC medical
SEK 0.060%-27.7%SEK 92.1mn/aPS2.3xn/an/a

SPERM

Spermosens
SEK 0.0160%-97.2%SEK 4.5mn/aPB0.2xn/an/a

SPAGO

Spago Nanomedical
SEK 0.190%-29.1%SEK 66.2mn/aPS9.5xE78.0%n/a

EEVIA

Eevia Health Oyj
SEK 0.250%-79.8%SEK 16.0mn/aPB0.6xn/an/a

SENZA

SenzaGen
SEK 7.000%-2.8%SEK 206.5mSEK 16.00PS3.5xE120.0%n/a

PROB

Probi
SEK 351.000%69.6%SEK 4.0bn/aPE367.5xE62.0%0.4%

ACUC

AcuCort
SEK 0.820%105.5%SEK 97.7mn/aPS14xn/an/a

XINT

Xintela
SEK 0.350%41.9%SEK 200.2mn/aPS525.5xn/an/a

ODI

ODI Pharma
SEK 3.300%-38.9%SEK 50.2mn/aPE141.1xn/an/a

ALZ

Alzinova
SEK 3.700%33.6%SEK 329.9mSEK 6.50PS19xE-39.4%n/a

WNT

WntResearch
SEK 0.69-0.9%-92.7%SEK 6.0mn/aPB0.2xS40.7%n/a

ZICC

Ziccum
SEK 1.00-0.9%-84.3%SEK 15.9mn/aPS2.8xn/an/a

PROGEN

Prostatype Genomics
SEK 7.80-1.9%-89.9%SEK 7.7mn/aPS1.9xn/an/a

BIOVIC B

Biovica International
SEK 1.80-0.1%-39.3%SEK 162.6mSEK 6.20PS22.5xE78.5%n/a

DIABIO

Diagonal Bio
SEK 0.033-1.8%-88.9%SEK 13.1mn/aPS10.9xn/an/a

RLS

RLS Global
SEK 0.45-0.7%-84.2%SEK 35.6mSEK 7.00PS33.1xE92.8%n/a

KAN

Kancera
SEK 1.08-0.2%-70.4%SEK 130.6mSEK 3.10PB1.6xE47.8%n/a

SCOL

Scandion Oncology
SEK 0.075-1.9%-96.1%SEK 17.5mn/aPB0.5xE69.7%n/a

ELIC

Elicera Therapeutics
SEK 1.76-1.4%-64.2%SEK 61.8mSEK 2.40PS5.1xE-15.2%n/a

SANION

Saniona
SEK 2.81-0.4%-60.7%SEK 314.4mSEK 6.00PS12.6xE40.2%n/a

RHOVAC

RhoVac
SEK 1.16-5.1%-95.7%SEK 22.1mn/aPB1.7xn/an/a

COEGIN

Coegin Pharma
SEK 4.01-1.7%-29.6%SEK 83.2mSEK 9.00PB3.8xE16.4%n/a
Page 3 of 5
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.